The Lyme disease spirochaete, Borrelia burgdorferi, produces the LuxS enzyme both in vivo and in vitro; this enzyme catalyses the synthesis of homocysteine and 4,5-dihydroxy-2,3-pentanedione (DPD) from a by-product of methylation reactions. Unlike most bacteria, B. burgdorferi is unable to utilize homocysteine. However, DPD levels alter expression levels of a subset of B. burgdorferi proteins. The present studies demonstrate that a single B. burgdorferi operon encodes both of the enzymes responsible for synthesis of DPD, as well as the enzyme for production of the Lyme spirochaete's only activated-methyl donor and a probable phosphohydrolase. Evidence was found for only a single transcriptional promoter, located 59 of the first gene, which uses the housekeeping s 70 subunit for RNA polymerase holoenzyme function. All four genes are co-expressed, and mRNA levels are growth-rate dependent, being produced during the exponential phase. Thus, high metabolic activity is accompanied by increased cellular levels of the only known borrelial methyl donor, enhanced detoxification of methylation by-products, and increased production of DPD. Therefore, production of DPD is directly correlated with cellular metabolism levels, and may thereby function as an extracellular and/or intracellular signal of bacterial health.
INTRODUCTIONLyme disease is an arthropod-borne zoonotic disease affecting humans and many domesticated and wild animals. The causative agent, Borrelia burgdorferi, is readily able to infect both Ixodes spp. ticks and a variety of vertebrate hosts (Steere, 2001). Throughout the processes of infecting these two distinct host types, and transmission between each, B. burgdorferi regulates expression of a large number of both metabolic and host-interface proteins. Deciphering the mechanisms by which B. burgdorferi controls gene and protein expression patterns is providing insights into both the physiology of this bacterium and its pathogenic abilities.Some species of bacteria utilize the metabolic by-product 4,5-dihydroxy-2,3-pentanedione (DPD) in intercellular (and possibly intracellular) signalling. Several different, spontaneously derived forms of DPD have been identified that can function as signals, which are collectively termed 'autoinducer-2' (AI-2) (Chen et al., 2002;Miller et al., 2004). DPD/AI-2 is produced from the toxic end product of transmethylation reactions, S-adenosylhomocysteine (SAH), in a two-step reaction catalysed by the enzymes Pfs and LuxS. Some bacteria, such as the syphilis spirochaete Treponema pallidum, possess Pfs but lack LuxS, and therefore detoxify SAH only to the non-toxic S-ribosylhomocysteine (SRH) (Fraser et al., 1998;von Lackum et al., 2006). Other bacteria, B. burgdorferi included, further degrade SRH to DPD and homocysteine via the LuxS enzyme (Babb et al., 2005;Stevenson & Babb, 2002;Stevenson et al., 2003;Sun et al., 2004;Xavier & Bassler, 2003). The majority of bacteria salvage homocysteine for regeneration of methionine, for use in additional transmethylation reactions or pr...